Relmada Therapeutics Inc [NASDAQ: RLMD] plunged by -$2.14 during the normal trading session on while it closed the day at $0.63.
Relmada Therapeutics Inc stock has also loss -76.84% of its value over the past 7 days. However, RLMD stock has declined by -73.97% in the 3 months of the year. Over the past six months meanwhile, it has lost -78.72% and lost -84.78% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for RLMD stock reached $19.01 million, with 30.17 million shares outstanding and 25.17 million shares in the current float. Compared to the average trading volume of 191.54K shares, RLMD reached a trading volume of 17553921 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Relmada Therapeutics Inc [RLMD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RLMD shares is $1.15 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RLMD stock is a recommendation set at 3.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Jefferies have made an estimate for Relmada Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 17, 2024. While these analysts kept the previous recommendation, Goldman dropped their target price from $3 to $2. The new note on the price target was released on June 05, 2024, representing the official price target for Relmada Therapeutics Inc stock. Previously, the target price had yet another drop from $90 to $10, while Truist kept a Hold rating on RLMD stock.
The Average True Range (ATR) for Relmada Therapeutics Inc is set at 0.40 The Price to Book ratio for the last quarter was 0.40, with the Price to Cash per share for the same quarter was set at 1.79.
RLMD stock trade performance evaluation
Relmada Therapeutics Inc [RLMD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -76.84. With this latest performance, RLMD shares dropped by -81.58% in over the last four-week period, additionally sinking by -78.72% over the last 6 months – not to mention a drop of -74.90% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RLMD stock in for the last two-week period is set at 16.71, with the RSI for the last a single of trading hit 14.09, and the three-weeks RSI is set at 19.85 for Relmada Therapeutics Inc [RLMD]. The present Moving Average for the last 50 days of trading for this stock 3.24, while it was recorded at 2.52 for the last single week of trading, and 3.67 for the last 200 days.
Relmada Therapeutics Inc [RLMD]: An insightful look at the core fundamentals
Relmada Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.89 and a Current Ratio set at 6.89.
Relmada Therapeutics Inc [RLMD]: Institutional Ownership
There are presently around $46.06%, or 50.09%% of RLMD stock, in the hands of institutional investors. The top three institutional holders of RLMD stocks are: VANGUARD GROUP INC with ownership of 1.26 million shares, which is approximately 4.1706%. DEEP TRACK CAPITAL, LP, holding 1.23 million shares of the stock with an approximate value of $$3.7 million in RLMD stocks shares; and DEEP TRACK CAPITAL, LP, currently with $$3.6 million in RLMD stock with ownership which is approximately 3.9825%.
